Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.

Reduced diabetes in btk-deficient nonobese diabetic mice and restoration of diabetes with provision of an anti-insulin IgH chain transgene.
复制标题

DOI:
10.4049/jimmunol.0900367
复制
发表时间:
2009-11-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Thomas JW
Thomas JW
中科院分区:
其他
文献类型:
--
作者:
Kendall PL;Moore DJ;Hulbert C;Hoek KL;Khan WN;Thomas JW

文献摘要

参考文献

被引文献

相似文献

1型糖尿病是由T细胞介导的对产生胰岛素的β细胞的破坏引起的。虽然消除B淋巴细胞已被证明在预防疾病方面是成功的,但调节B细胞功能作为预防1型糖尿病的手段尚未被研究。B淋巴细胞的发育、命运和功能依赖于BCR信号传导,其部分由布鲁顿酪氨酸激酶(BTK)介导。当引入NOD小鼠时,btk缺陷仅适度减少B细胞数量,但显着防止糖尿病。在NOD中,btk缺陷反映了在其他菌株中观察到的B细胞亚群的变化,但也改善了B细胞相关的耐受性,如不能产生胰岛素自身抗体所示。抗胰岛素BCR H链转基因的引入恢复了btk缺陷型NOD小鼠的糖尿病,表明如果btk缺陷型B细胞具有关键的自身免疫特异性,则它们在功能上能够促进自身免疫糖尿病。这表明btk缺陷的疾病保护作用可能反映了B细胞库中自身反应特异性的缺乏。因此,可以调节经由BTK的信号传导以改善B细胞耐受性,并预防T细胞介导的自身免疫性糖尿病。
Type 1 diabetes results from T cell-mediated destruction of insulin-producing β cells. Although elimination of B lymphocytes has proven successful at preventing disease, modulation of B cell function as a means to prevent type 1 diabetes has not been investigated. The development, fate, and function of B lymphocytes depend upon BCR signaling, which is mediated in part by Bruton’s tyrosine kinase (BTK). When introduced into NOD mice, btk deficiency only modestly reduces B cell numbers, but dramatically protects against diabetes. In NOD, btk deficiency mirrors changes in B cell subsets seen in other strains, but also improves B cell-related tolerance, as indicated by failure to generate insulin autoantibodies. Introduction of an anti-insulin BCR H chain transgene restores diabetes in btk-deficient NOD mice, indicating that btk-deficient B cells are functionally capable of promoting autoimmune diabetes if they have a critical autoimmune specificity. This suggests that the disease-protective effect of btk deficiency may reflect a lack of autoreactive specificities in the B cell repertoire. Thus, signaling via BTK can be modulated to improve B cell tolerance, and prevent T cell-mediated autoimmune diabetes.
DOI: 10.4049/jimmunol.178.9.5643
发表时间: 2007-05-01
影响因子: 4.4
作者:
Kendall, Peggy L.;Yu, Guowu;Thomas, James W.
通讯作者: Thomas, James W.
DOI: 10.1172/jci32405
发表时间: 2007-12-01
影响因子: 15.9
作者:
Hu, Chang-Yun;Rodriguez-Pinto, Daniel;Wen, Li
通讯作者: Wen, Li
DOI: 10.4049/jimmunol.165.5.2841
发表时间: 2000-09-01
影响因子: 4.4
作者:
Balasa, B;Van Gunst, K;Sarvetnick, N
通讯作者: Sarvetnick, N
DOI: 10.1016/0008-8749(83)90287-3
发表时间: 1983-01-01
影响因子: 4.3
作者:
PISETSKY, DS;CASTER, SA;STEINBERG, AD
通讯作者: STEINBERG, AD